Stem cell transplantation programme at Singapore General Hospital

Bone Marrow Transplantation

Volumn 42, Issue SUPPL.1, 2008, Pages

  Koh, M B C ^a,b   Goh, Y T ^a   Tan, P H C ^a   Koh, L P ^a   Hwang, W Y K ^a   Loh, Y ^a   Tan, D ^a   Ng, H J ^a   Chuah, C ^a   Lim, T J ^b   Niam, M ^b   Suck, G ^b   Chan, M ^b   Phang, C Y ^b   Lee, J J ^a   Wee, V ^a   Ng, H Y ^a   Lim, C H ^a   Yiu, R ^a   Kam, G ^a   Ang, A ^a   Linn, Y C ^a   more..

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b HEALTH SCIENCES AUTHORITY   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ERYTHROPOIETIN; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; METHOTREXATE; METHOXSALEN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OXYMETHOLONE; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ALLOGENEIC STEM CELL TRANSPLANTATION; APLASTIC ANEMIA; AUTOIMMUNE DISEASE; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL PROTOCOL; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOMEGALOVIRUS INFECTION; DONOR LYMPHOCYTE INFUSION; GENERAL HOSPITAL; GOOD MANUFACTURING PRACTICE; HEALTH PROGRAM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INCIDENCE; KILLER CELL; LUNG MYCOSIS; NONMYELOABLATIVE STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; PUVA; REVIEW; SINGAPORE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

ADULT; FEMALE; GRAFT VS HOST DISEASE; HAPLOTYPES; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; MALE; MIDDLE AGED; SINGAPORE;

EID: 50549089232     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.139     Document Type: Review

References (8)

1. Tan DCL, Hsu LY, Koh LP, Gob YT, Koh M. Severe conidiobolomycosis complicating induction chemotherapy in a patient with acute lymphoblastic leukaemia. Br J Haematol 2005; 129: 447.
2. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ et al. Posaconazole vs fluconazole or itraconazole prophylaxis in patients with neutropenia. N Eng J Med 2007; 356: 348-359.
3. Koh LP, Koh MBC, Gob YT, Tan P. Allogeneic HSCT for patients with severe aplastic anaemia following non myeloablative conditioning with 200 cGy TBI and fludarabine. Biol Bone Marrow Transplant 2006; 12: 887-890.
4. Koh LP, Chen CS, Tai BC, Hwang WY, Tan LK, Koh MBC et al. The impact of post grafting immunosuppression on non relapse mortality and survival after non myeloablative transplantation using fludarabine and 200 cGy total body irradiation. Biol Blood Marrow Transplant 2007; 13: 790-805.
5. Koh MBC, Prentice HG, Corbo M, Cotter FE, Morgan M, Lowdell MW. Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. Br J Haematol 2002; 118: 108-116.
6. Koh MBC, Lim TJ, Niam M, Suck G, Chan M, Goh YT et al. A Translational Clinical Trial to evaluate the safety and efficacy of graded infusions of ex-vivo expanded cytokine induced killer (CIK) cells for haematologic malignancies. Cytotherapy 2007, abstract.
7. Linn YC, Wang SM, Hui KM. Comparative gene expression profiling of cytokine-induced killer cells in response to acute myloid leukemic and acute lymphoblastic leukemic stimulators using oligonucleotide arrays. Exp Haem 2005; 33: 671-681.
8. Suck G. Novel approaches using natural killer cells in cancer therapy. Semin Cancer Biol 2006; 16: 412-418.